Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

If you are anything like us, whenever you plan a journey, you spend a remarkable amount of time thinking about the start and ...

One of the greatest weaknesses of AI agents that read and understand vast amounts of enterprise data is "hallucination"—the ...

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

So far, we have seen how demand surrounding HBM passes through three layers. In Layer 1, demand is inscribed as a "reservation"; in Layer 2, that reservation hits physical constraints and is converted ...

Andrej Karpathy, one of the most respected researchers in artificial intelligence (AI), recently became the face of a massive tech-regulation scare at Anthropic. Rumors claimed he couldn't access his ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

RSI is also defined as an “AI system capable of fully autonomously designing and developing its own successor,” per Anthropic’s blog post. “We are not there yet, and recursive self-improvement is not ...

Companies have been developing AI very quickly to stay ahead of the market, but Favaro and Clark argue that a slowdown would allow more time to deal with the technology’s implications. US-based AI ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...